Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia.

MLA

Ritis, Konstantinos, et al. “Absence of Bruton’s Tyrosine Kinase (Btk) Mutations in Patients with Acute Myeloid Leukaemia.” British Journal of Haematology, vol. 102, no. 5, Sept. 1998, pp. 1241–48. EBSCOhost, https://doi.org/10.1046/j.1365-2141.1998.00914.x.

APA

Ritis, K., Speletas, M., Tsironidou, V., Pardali, E., Kanariou, M., Moschese, V., Orlandi, P., Skordala, M., Rossi, P., Kartalis, G., Bourikas, G., & Sideras, P. (1998). Absence of Bruton’s tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia. British Journal of Haematology, 102(5), 1241–1248. https://doi.org/10.1046/j.1365-2141.1998.00914.x

Chicago

Ritis, Konstantinos, Matthaios Speletas, Victoria Tsironidou, Evaggelia Pardali, Maria Kanariou, Viviana Moschese, Paola Orlandi, et al. 1998. “Absence of Bruton’s Tyrosine Kinase (Btk) Mutations in Patients with Acute Myeloid Leukaemia.” British Journal of Haematology 102 (5): 1241–48. doi:10.1046/j.1365-2141.1998.00914.x.